新医改制度下对于药品零售企业监管的思考——以四川省Z市为例.pdfVIP

西南政法大学硕士学位论文 Abstract Accompany with the development of national health system, the Chinese government has published numbers of the medical reform’s supporting policies in order to regulate the market order of the drug distribution from the year of 2012. In the supporting polices, some are associated with drug retailing enterprises, such as “China’s 12th Five-Year Plan of National Drug Safety” and the revised “Good Supply Practice”. The standards make new demands on so many aspects, such as the implementation of quality control system, qualification of medicine practitioners, computer information management, electronic supervision of drug, hardware facilities and daily management. The thesis reviews the history of China’s drug retail industry and the process of governmental regulation, exemplified with the drug retail enterprises in the Z city, and then investigates the aspects of practitioners, hardware facilities, distribution area, operating conditions. The thesis explains the problems that drug retailing enterprises face, such as imbalanced distribution, small-scale operations, low standard of quality management, and lack of licensed pharmacists. By using the experiences of other countries’ management of medical regulation and human resources, the thesis makes innovations on the state superintendence of drug retailing enterprises and licensed pharmacists shall implement under the environment of new medical reform decentralized administration, which presents the examples and inspirations for the governmental regulation of d